Health Condition 1: H102- Other acute conjunctivitis
Conditions
Interventions
Intervention1: Antihistaminic - Topical Alcaftadine 0.25%: Topical Alcaftadine 0.25% eyedrop once a day for 14 days
Control Intervention1: Antihistaminic- Topical Bepotastine besilate 1.5%: Topical Be
Sponsors
Rama medical College Hospital and Research Centre ,Kanpur
Eligibility
Inclusion criteria
Inclusion criteria: 1.Mild to moderate allergic conjunctivitis 2.Patient with both the sexes in ages18-60 years of age 3.Having one or more clinical feature of allergic conjunctivitis such as Itching, Tearing , Redness , Swelling according to TOSS (grade 1+ and grade 2+) and hyperemia score grade 0.5 and 2. 4. willing to give written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients with severe allergic conjunctivitis, need for topical steroids or topical immunosuppressive 2.TOSS grade 3 + and hyperemia score grades 3 i.e severe allergic conjunctivitis will be excluded 3.Contact lens wearers 4.Patients with an intra-ocular pressure of more than 21 mm Hg in either eye or any type of glaucoma 5.History of hypersensitivity to the study medications or their components (including benzalkonium chloride) 6.History of an ocular herpetic infection 7.An active ocular infection 8.Any significant systemic illness (eg. Hypertension, T2DM, CAD, CKD) 9.Taking systemic steroids or oral antihistamines currently or within 7 days prior to enrolment 10.Pregnant women, planning pregnancy, / lactating 11.use of any other topical ocular medications were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TOSS SCORE, Hyperemia score Physical examination Ophthalmologic examinationTimepoint: day0 , day7 and day 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mohammd Waseem Khan
Rama Medical College Hospital and Research Centre, Kanpur
Outcome results
None listed